Teva Pharmaceutical Industries [clinicaltrials_resource:4a89e46ba43af85a198c0c303d967957]
Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas [clinicaltrials:NCT00062504]Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD) [clinicaltrials:NCT00104273]A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel [clinicaltrials:NCT00868361]clinicaltrials:NCT00936676A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm [clinicaltrials:NCT00964730]clinicaltrials:NCT00977665clinicaltrials:NCT00991510clinicaltrials:NCT01188187Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP) [clinicaltrials:NCT01202786]A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids [clinicaltrials:NCT01479621]A Clinical Study in Cancer Patients to Investigate the Potential Impact of Custirsen, on the Blood Levels of the Chemotherapeutic Drug, Paclitaxel, When Given Together as Part of a Treatment Regimen [clinicaltrials:NCT01497470]Adenovirus Vaccine Pregnancy Registry [clinicaltrials:NCT01584037]Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis [clinicaltrials:NCT01632540]clinicaltrials:NCT01792583A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine [clinicaltrials:NCT02025556]
collaborator [clinicaltrials_vocabulary:collaborator]
Multicenter Trial for Adults With Partial Seizures [clinicaltrials:NCT00034814]Effects of Talampanel on Patients With Advanced Parkinson's Disease [clinicaltrials:NCT00036296]Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas [clinicaltrials:NCT00062504]Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors [clinicaltrials:NCT00071539]Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors [clinicaltrials:NCT00104091]Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD) [clinicaltrials:NCT00104273]A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose [clinicaltrials:NCT00202982]Randomized Study Designed to Look at Disease Progression Using 2 Currently FDA Approved Drugs for the Treatment of RRMS [clinicaltrials:NCT00202995]A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma [clinicaltrials:NCT00203008]Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness. [clinicaltrials:NCT00203021]Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations [clinicaltrials:NCT00203034]clinicaltrials:NCT00203047A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis. [clinicaltrials:NCT00203073]A Study to Evaluate the Long Term Safety and Effectiveness of Novantrone Therapy Followed by Copaxone Treatment for Multiple Sclerosis [clinicaltrials:NCT00203086]Safety and Efficacy Study of Copaxone Administered in Combination With N-Acetylcysteine [clinicaltrials:NCT00203099]Safety and Efficacy Study of Copaxone Administered in Combination With Minocycline [clinicaltrials:NCT00203112]A Study to Evaluate the Effects of Tyramine in Patients Who Completed the PRESTO Study. [clinicaltrials:NCT00203125]Safety, Tolerability, and Effectiveness of Rasagiline Mesylate in Patients With Parkinson's Disease [clinicaltrials:NCT00203138]A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus [clinicaltrials:NCT00203151]Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients [clinicaltrials:NCT00203164]Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy. [clinicaltrials:NCT00203177]A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone® [clinicaltrials:NCT00239993]A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®. [clinicaltrials:NCT00240032]clinicaltrials:NCT00256204Safety and Efficacy of Talampanel in Glioblastoma Multiforme [clinicaltrials:NCT00267592]Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00326625]Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy [clinicaltrials:NCT00336557]clinicaltrials:NCT00337779A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod [clinicaltrials:NCT00349193]Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) [clinicaltrials:NCT00509145]BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®) [clinicaltrials:NCT00605215]A Study of Treatment With ACR16 in Patients With Huntington's Disease [clinicaltrials:NCT00665223]clinicaltrials:NCT00666224Talampanel for Amyotrophic Lateral Sclerosis (ALS) [clinicaltrials:NCT00696332]A Study of ACR16 for the Treatment of Patients With Huntington's Disease [clinicaltrials:NCT00724048]Laquinimod Phase IIa Study in Active Crohn's Disease [clinicaltrials:NCT00737932]An Open Label Extension of the LAQ/5062 and LAQ/5063 Studies to Assess the Long Term Safety and Tolerability of Laquinimod 0.6mg in RRMS Patients [clinicaltrials:NCT00745615]Neugranin in Breast Cancer Patients Receiving Doxorubicin/Docetaxel [clinicaltrials:NCT00837265]clinicaltrials:NCT00856635A Study to Investigate the Absorption, Metabolism and Excretion of Talampanel [clinicaltrials:NCT00868361]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation [clinicaltrials:NCT00030186]Multicenter Trial for Adults With Partial Seizures [clinicaltrials:NCT00034814]Multicenter Trial For Patients With Acute Crohn's Disease [clinicaltrials:NCT00035503]Effects of Talampanel on Patients With Advanced Parkinson's Disease [clinicaltrials:NCT00036296]Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease [clinicaltrials:NCT00040404]Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique [clinicaltrials:NCT00054964]Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas [clinicaltrials:NCT00062504]Safety and Activity of SDX-105 (Bendamustine) in Patients With Rituximab Refractory Non-Hodgkin's Lymphoma [clinicaltrials:NCT00069758]Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors [clinicaltrials:NCT00071539]Efficacy of QVAR vs Flovent Diskus on Small Airways in Poorly Controlled Asthmatic Adolescents/Adult Patients [clinicaltrials:NCT00071552]SDX-105 in Combination With Rituxan for Patients With Relapsed Indolent or Mantle Cell Non-Hodgkin's Lymphoma (NHL) [clinicaltrials:NCT00076349]Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder [clinicaltrials:NCT00078312]Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS) [clinicaltrials:NCT00078325]Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy [clinicaltrials:NCT00078377]Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML) [clinicaltrials:NCT00079482]Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) Syndrome [clinicaltrials:NCT00079677]Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSD [clinicaltrials:NCT00080288]Study of CEP-701 in Treatment of Prostate Cancer [clinicaltrials:NCT00081601]Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma [clinicaltrials:NCT00085774]Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic Children [clinicaltrials:NCT00094016]Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors [clinicaltrials:NCT00104091]Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD) [clinicaltrials:NCT00104273]Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients [clinicaltrials:NCT00105287]OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients [clinicaltrials:NCT00105937]Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy [clinicaltrials:NCT00107796]Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome [clinicaltrials:NCT00107809]PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome [clinicaltrials:NCT00107848]Evaluation of Two Doses of QVAR Versus Placebo by Breath Operated and Metered Dose Inhalers in Moderate Asthmatic Adolescents and Adults on a Stable Regimen of Inhaled Corticosteroids [clinicaltrials:NCT00109668]Comparison of Two Bronchodilator Inhalers in Pediatric Asthmatics [clinicaltrials:NCT00112411]clinicaltrials:NCT00114959Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density [clinicaltrials:NCT00117260]A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens [clinicaltrials:NCT00117273]clinicaltrials:NCT00117468Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain [clinicaltrials:NCT00117481]Safety and Efficacy of Treanda™ (Bendamustine HCl) in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Who Are Refractory to Rituximab [clinicaltrials:NCT00139841]Safety and Efficacy of SDX-101 (R-Etodolac) in Combination With Chlorambucil, and That of Chlorambucil Alone, in Patients With Chronic Lymphocytic Leukemia (CLL) [clinicaltrials:NCT00151736]clinicaltrials:NCT00196313clinicaltrials:NCT00196339A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive. [clinicaltrials:NCT00196352]A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain [clinicaltrials:NCT00196365]
source [clinicaltrials_vocabulary:source]
Teva Pharmaceutical Industries [clinicaltrials_resource:4a89e46ba43af85a198c0c303d967957]
Bio2RDF identifier
4a89e46ba43af85a198c0c303d967957
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:4a89e46ba43af85a198c0c303d967957
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:4a89e46ba43af85a198c0c303d967957
title
Teva Pharmaceutical Industries
@en
type
label
Teva Pharmaceutical Industries [clinicaltrials_resource:4a89e46ba43af85a198c0c303d967957]
@en